Zu "51037-30-0" wurden 3 Artikel gefunden!
Für die Filterung wurden keine Ergebnisse gefunden!
Acipimox
Artikelnummer: TGM-T1162-100mg
Description: Acipimox (K-9321) is a niacin derivative and nicotinic acid analog with activity as a hypolipidemic agent. Acipimox has special application for the treatment of hyperlipidemia in non-insulin-dependent diabetic patients. Target: Others. Smiles: C(O)(=O)C=1C=N(=O)C(C)=CN1. References: Jin F, et al....
| Schlagworte: | K-9321, Olbemox |
| CAS | 51037-30-0 |
| MW: | 154.12 D |
ab 31,00 €
Acipimox
Artikelnummer: LKT-A0833.1
Yellowish white crystalline powder. Acipimox inhibits lipolysis in peripheral tissues and induces large reduction in circulatingserum-free fatty acids. The mechanism of triglyceride lowering appears to be an increase of VLDL-Tg clearance.
| Anwendung: | Metabolic studies |
| CAS | 51037-30-0 |
| MW: | 154,12 D |
ab 128,00 €
Acipimox
Artikelnummer: Cay26090-500
Acipimox is an antilipolytic agent. It inhibits lipolysis induced by noradrenaline and theophylline in rat epididymal adipocytes when used at a concentration of 1 µM. Acipimox (3 and 12 mg/kg, p.o.) decreases plasma free fatty acid levels in rats. It reduces plasma fatty acid concentration, the number of...
| Schlagworte: | 5-methyl-2-pyrazinecarboxylic acid, 4-oxide |
| Anwendung: | Hypolipidemic agent, lipolysis inhibitor |
| CAS | 51037-30-0 |
| MW: | 154.1 D |
ab 61,00 €
